Medicure (TSXV:MPH) Total Liabilities: C$10.73 Mil (As of Mar. 2026)


TSXV:MPH Medicure Inc TSXV:MPH
61 GF Score
Price C$1.29
GF Value C$1.56
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Medicure Total Liabilities?

Medicure TSXV:MPH 61 Total Liabilities is C$10.73 Mil as of Mar. 2026. GuruFocus rates TSXV:MPH with a GF Score™ of 61/100 and a GF Value™ of C$1.56 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Medicure's Total Liabilities for the quarter that ended in Mar. 2026 was C$10.73 Mil.

Medicure's quarterly Total Liabilities increased from Sep. 2025 (C$9.42 Mil) to Dec. 2025 (C$12.04 Mil) but then declined from Dec. 2025 (C$12.04 Mil) to Mar. 2026 (C$10.73 Mil).

Medicure's annual Total Liabilities increased from Dec. 2023 (C$8.16 Mil) to Dec. 2024 (C$8.90 Mil) and increased from Dec. 2024 (C$8.90 Mil) to Dec. 2025 (C$12.04 Mil).

Medicure Total Liabilities Historical Data

* Premium members only.

The historical data trend for Medicure's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicure Total Liabilities Chart

Medicure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.00 8.89 8.16 8.90 12.04

Medicure Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.68 10.11 9.42 12.04 10.73
TSXV:MPH
61GF Score
Medicure Inc TSXV:MPH
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicure Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Medicure's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.613+(0.427+-3.885780586188E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=12.04

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=24.949-12.909
=12.04

Medicure's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10.363+(0.348+0.02
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=10.73

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=23.378-12.647
=10.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of C$10.73 Mil mean?
Medicure (TSXV:MPH) has a Total Liabilities of C$10.73 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Medicure and its competitors.
Is Medicure's Total Liabilities too high?
Medicure's current Total Liabilities is C$10.73 Mil. Overall, Medicure has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medicure's Total Liabilities compare to ZTS and UTHR?
Medicure's Total Liabilities of C$10.73 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Medicure and its competitors. Medicure's current Total Liabilities is C$10.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicure stock overvalued right now?
Based on GuruFocus' analysis, Medicure (TSXV:MPH) is currently considered Modestly Undervalued. The stock's GF Value™ is C$1.56, compared to a current price of C$1.29 — trading 17.3% below its estimated fair value. The current Total Liabilities is C$10.73 Mil. Medicure's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Medicure (TSXV:MPH), the current Total Liabilities is C$10.73 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicure (TSXV:MPH) Overvalued in 2026?

Based on GuruFocus' analysis, Medicure stock appears to be undervalued. The current stock price of C$1.29 is trading 17.3% below its estimated GF Value™ of C$1.56. GuruFocus considers Medicure to be Modestly Undervalued.

Key valuation signals for TSXV:MPH:

  • Total Liabilities: C$10.73 Mil
  • GF Value™: C$1.56 vs. price of C$1.29 (17.3% below fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the TSXV:MPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicure Business Description

Other Exchanges MCUJF:USA
Address 1250 Waverley Street, No. 2, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.
61GF Score

Get the complete analysis for TSXV:MPH

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.29
Price
C$1.56
GF Value